SCHEMBL7813623

SCHEMBL7813623

OC(CCCCBr)(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
SIGMAR1 Q99720 1/20 0.41
BCL2 P10415 2/20 0.39
PTPN1 P18031 1/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HTT P42858 2/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 1/20 0.38
USP2 O75604 1/20 0.37
RAB9A P51151 1/20 0.37
CYP19A1 P11511 1/20 0.35
CHRM4 P08173 4/20 0.35
CHRM5 P08912 4/20 0.35
CHRM3 P20309 4/20 0.35
CHRM2 P08172 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5099673 0.98 CYP3A4 (0.42) CYP3A4CYP2D6CYP2C9CYP2C19SIGMAR1
SCHEMBL23880652 0.82 CYP2D6 (0.44) CYP3A4CYP2D6CYP2C9CYP2C19SIGMAR1
SCHEMBL5089212 0.80 SIGMAR1 (0.61) CYP2D6SIGMAR1BCL2LMNACHRM4
SCHEMBL11836940 0.78 CYP3A4 (0.44) CYP3A4CYP2D6CYP2C9CYP2C19SIGMAR1
SCHEMBL5091772 0.78 SIGMAR1 (0.59) CYP2D6SIGMAR1BCL2LMNACHRM4
SCHEMBL5093688 0.78 SIGMAR1 (0.59) CYP2D6SIGMAR1BCL2LMNACHRM4
SCHEMBL11024439 0.77 CYP3A4 (0.50) CYP3A4CYP2D6CYP2C9CYP2C19PTPN1
SCHEMBL11868000 0.73 BCL2 (0.49) CYP2D6SIGMAR1BCL2KMT2AL3MBTL1
SCHEMBL6352845 0.72 SIRT2 (0.33) CYP3A4CYP2D6CYP2C9CYP2C19PTPN1
SCHEMBL3885050 0.70 CYP3A4 (0.52) CYP3A4CYP2D6CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0727421-B1 Agents for improving sleep JANSSEN PHARMACEUTICA NV (BE) 2001-10-24 EP disclosed
EP-0727421-A1 Agents for improving sleep JANSSEN PHARMACEUTICA N.V. (BE) 1996-08-21 EP disclosed
US-5026853-A Sleep and cardiovascular disorders JANSSEN PHARMACEUTICA N.V. (BE) 1991-06-25 US disclosed
US-4968684-A N-ARYL-PIPERAZINEALKANAMIDE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1990-11-06 US disclosed
US-4880808-A SEDATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1989-11-14 US disclosed
EP-0285219-A2 Method of improving sleep JANSSEN PHARMACEUTICA N.V. (BE) 1988-10-05 EP disclosed